PuSH - Publication Server of Helmholtz Zentrum München: Nonsuppressed glucagon after glucose challenge as a potential predictor for glucose tolerance.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Wagner, R. ; Hakaste, L.H.* ; Ahlqvist, E.* ; Heni, M. ; Machann, J. ; Schick, F.* ; Van Obberghen, E.* ; Stefan, N. ; Gallwitz, B. ; Tuomi, T.* ; Häring, H.-U. ; Groop, L.* ; Fritsche, A.

Nonsuppressed glucagon after glucose challenge as a potential predictor for glucose tolerance.

Diabetes 66, 1373-1379 (2017)

Publ. Version/Full Text

Research data

DOI

PMC

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Glucagon levels are classically suppressed after glucose challenge. It is still not clear as to whether a lack of suppression contributes to hyperglycemia and thus to the development of diabetes. We investigated the association of postchallenge change in glucagon during oral glucose tolerance tests (OGTTs), hypothesizing that higher postchallenge glucagon levels are observed in subjects with impaired glucose tolerance (IGT). Glucagon levels were measured during OGTT in a total of 4,194 individuals without diabetes in three large European cohorts. Longitudinal changes in glucagon suppression were investigated in 50 participants undergoing a lifestyle intervention. Only 66-79% of participants showed suppression of glucagon at 120 min (fold change glucagon(120/0) <1) during OGTT, whereas 21-34% presented with increasing glucagon levels (fold change glucagon(120/0) 1). Participants with nonsuppressed glucagon(120) had a lower risk of IGT in all cohorts (odds ratio 0.44-0.53, P < 0.01). They were also leaner and more insulin sensitive and had lower liver fat contents. In the longitudinal study, an increase of fold change glucagon(120/0) was associated with an improvement in insulin sensitivity (P = 0.003). We characterize nonsuppressed glucagon(120) during the OGTT. Lower glucagon suppression after oral glucose administration is associated with a metabolically healthier phenotype, suggesting that it is not an adverse phenomenon.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

8.684

2.019